Note: Ingredients listed on restricted chemical lists
EC/CAS
7772-98-7
Name of the chemical
sodium thiosulphate
Concentration
< 0.001
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
~ 100
General Information
Revision date
2016-01-21
Product name
SODIUM
Product Synonyms
I-123 Diagnostic Capsules * I-123 Capsules
1.2.1 Relevant identified uses
The content of this kit as sold is radioactive. Administration of Sodium Iodide I-123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology
1.2.2. Uses advised against
Recommended restrictions
Manufacturer Name
Mallinckrodt Nuclear Medicine LLC
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
Mallinckrodt Nuclear Medicine LLC
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
OSHA identification
Physical hazards
Physical hazards Not classified.
Health hazards
Health hazards Reproductive toxicity Effects on or via lactation Specific target organ toxicity, single exposure Category 1 (Thyroid)
Environmental hazards
Environmental hazards Not classified. OSHA OSHA defined defined defined hazards Not classified.
Contains
Sodium Iodide I-123, SODIUM THIOSULFATE, SUCROSE Label
2.2 Label elements
elements
Signal word
Signal word Danger
Hazard statements
Hazard statement May cause harm to breast-fed children. Causes damage to organs (Thyroid). RADIOACTIVE MATERIAL HANDLE ACCORDING TO ALL FEDERAL AND STATE REGULATIONS GOVERNING THE USE OF RADIOACTIVE MATERIAL Precautionary
Prevention
Obtain special instructions before use. Do not breathe dust. Do not eat, drink or smoke when using this product. Avoid contact during pregnancy/while nursing. Wash thoroughly after handling. Avoid contact with the radioactive contents which would cause unnecessary exposure to radiation. Radioactive drugs must be handled by qualified personnel only. Read Package Insert prior to use. Promptly remove any contamination from the skin, eyes, or clothing. Observe good industrial hygiene practices.
Response
Notify radiation safety personnel immediately. The amount of material inhaled should be assessed and documented. The amount of material ingested should be assessed and documented. Wash hands after handling. If exposed or concerned: Get medical advice/attention.
Storage
Store locked up. The vial containing the drug should be kept within its container or within heavier shielding. Avoid contact with the radioactive content. Store away from incompatible materials.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) Hazard(s) not not not otherwise otherwise None known.
Classified (HNOC)
classified (HNOC)
Additional information
Supplemental information The contents of the capsule are radioactive. Adequate shielding of the preparation must be maintained at all times. As per 29 CFR 1910.1200(b)(6)(xi), ionizing and nonionizing radiation are outside the scope and application of the Hazard Communication Standard, although the radioactive material should be considered the principle hazard of the material. This material should only be handled by trained individuals in conformance with the requirements of applicable regulations. Radioactive materials in the US are not subject to OSHA regulations. The US Nuclear Regulatory Comission (NRC) is the Federal agency responsible protecting the health and safety of the public and the environment by licensing and regulating the civilian uses of the radioactive materials. CAUTION! RADIOACTIVE MATERIAL. Read Package Insert prior to use. Promptly remove any contamination from the skin, eyes, or clothing. Radioactive drugs must be handled by qualified personnel in conformity with regulations appropriate to the government agency authorized to license the use of this radionuclide. The vial containing the drug should be kept within its container or within heavier shielding. Avoid contact with the radioactive contents which would cause unnecessary exposure to radiation. 3. 3. 3. 3. Composition/information